Quanterix Corporation Cash and Cash Equivalents, Period Increase (Decrease)
Quanterix Corporation (QTRX) reported Cash and Cash Equivalents, Period Increase (Decrease) of -$14.45 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-15.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2018-05-15
- Quanterix Corporation cash and cash equivalents, period increase (decrease) for the quarter ending 2018-03-31 was -$14.45M.
- Quanterix Corporation cash and cash equivalents, period increase (decrease) for the quarter ending 2017-03-31 was -$5.11M.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month |
|---|---|
| 2018-03-31 | -$14.45M 10-Q · filed 2018-05-15 |
| 2017-03-31 | -$5.11M 10-Q · filed 2018-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |